X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs TORRENT PHARMA - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE TORRENT PHARMA CADILA HEALTHCARE/
TORRENT PHARMA
 
P/E (TTM) x 17.4 37.7 46.2% View Chart
P/BV x 3.9 6.6 58.7% View Chart
Dividend Yield % 1.0 0.8 136.1%  

Financials

 CADILA HEALTHCARE   TORRENT PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
TORRENT PHARMA
Mar-18
CADILA HEALTHCARE/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs5581,550 36.0%   
Low Rs3621,144 31.6%   
Sales per share (Unadj.) Rs116.3354.7 32.8%  
Earnings per share (Unadj.) Rs17.940.1 44.6%  
Cash flow per share (Unadj.) Rs23.164.2 36.0%  
Dividends per share (Unadj.) Rs3.5014.00 25.0%  
Dividend yield (eoy) %0.81.0 73.2%  
Book value per share (Unadj.) Rs85.4273.1 31.3%  
Shares outstanding (eoy) m1,023.74169.22 605.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.03.8 104.1%   
Avg P/E ratio x25.733.6 76.6%  
P/CF ratio (eoy) x19.921.0 94.8%  
Price / Book Value ratio x5.44.9 109.2%  
Dividend payout %19.634.9 56.1%   
Avg Mkt Cap Rs m470,664227,897 206.5%   
No. of employees `00011.814.7 80.4%   
Total wages/salary Rs m18,54511,353 163.4%   
Avg. sales/employee Rs Th10,072.74,083.0 246.7%   
Avg. wages/employee Rs Th1,569.1772.3 203.2%   
Avg. net profit/employee Rs Th1,547.7461.3 335.5%   
INCOME DATA
Net Sales Rs m119,04960,021 198.3%  
Other income Rs m1,1322,988 37.9%   
Total revenues Rs m120,18163,009 190.7%   
Gross profit Rs m28,47513,493 211.0%  
Depreciation Rs m5,3884,086 131.9%   
Interest Rs m9113,085 29.5%   
Profit before tax Rs m23,3089,310 250.4%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,6442,529 223.2%   
Profit after tax Rs m18,2926,781 269.7%  
Gross profit margin %23.922.5 106.4%  
Effective tax rate %24.227.2 89.2%   
Net profit margin %15.411.3 136.0%  
BALANCE SHEET DATA
Current assets Rs m82,00552,623 155.8%   
Current liabilities Rs m60,72052,022 116.7%   
Net working cap to sales %17.91.0 1,784.1%  
Current ratio x1.41.0 133.5%  
Inventory Days Days73120 61.2%  
Debtors Days Days9876 129.0%  
Net fixed assets Rs m83,70385,016 98.5%   
Share capital Rs m1,024846 121.0%   
"Free" reserves Rs m86,42145,376 190.5%   
Net worth Rs m87,44546,222 189.2%   
Long term debt Rs m25,55141,115 62.1%   
Total assets Rs m180,653142,432 126.8%  
Interest coverage x26.64.0 661.6%   
Debt to equity ratio x0.30.9 32.8%  
Sales to assets ratio x0.70.4 156.4%   
Return on assets %10.66.9 153.5%  
Return on equity %20.914.7 142.6%  
Return on capital %22.014.2 154.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42,68314,580 292.7%   
Fx outflow Rs m11,2423,600 312.3%   
Net fx Rs m31,44110,980 286.3%   
CASH FLOW
From Operations Rs m9,1938,942 102.8%  
From Investments Rs m-9,737-47,070 20.7%  
From Financial Activity Rs m51534,174 1.5%  
Net Cashflow Rs m-29-3,655 0.8%  

Share Holding

Indian Promoters % 74.8 71.5 104.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 7.0 118.2%  
FIIs % 5.9 12.6 46.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 8.8 125.0%  
Shareholders   44,069 26,511 166.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   FULFORD INDIA  VENUS REMEDIES  STERLING BIOTECH  WOCKHARDT  SUVEN LIFESCIENCES  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Lower; Reliance Industries & Yes Bank Top Losers(12:30 pm)

Share markets in India are presently trading on a negative note. Barring IT sector, all sectoral indices are trading in red with realty stocks.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended December 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 324.1% YoY). Sales on the other hand came in at Rs 21 bn (up 38.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 12.3% YoY). Sales on the other hand came in at Rs 19 bn (up 32.5% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Apr 22, 2019 01:21 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS